NCT03210688View on ClinicalTrials.gov

Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

February 14, 2024

Study Completion Date

January 21, 2025

Conditions
Minimal Change DiseaseNephrotic Syndrome
Interventions
DRUG

Prednisolone

Tablet prednisolone

DRUG

Alfacalcidol

Capsule alfacalcidol 0,5 microgram/day

Trial Locations (2)

Unknown

Aarhus University Hospital, Aarhus

Regional Hospital Viborg, Viborg

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT03210688 - Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy | Biotech Hunter | Biotech Hunter